We have shown that COX-2-mediated VEGF-C upregulation in human breast cancer served as a stimulus for lymphangiogenesis, a vehicle for lymphatic metastasis (Timoshenko et al, 2006). The gene discussed is VEGFC; the disease is breast carcinoma.